E. Cortese

Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer

I. Frahm, J. Roa, M. Mercogliano, 2017, BMC Cancer.

Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis

J. Roa, L. Venturutti, Cecilia J. Proietti, 2020, Hormones and Cancer.

MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1

J. Cidlowski, J. Roa, P. Yankilevich, 2016, Oncogene.

Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer

I. Frahm, J. Roa, M. Mercogliano, 2017, BMC Cancer.